Certara narrows 2025 revenue outlook to $415M–$420M as Tier 1 services soften while software and QSP show resilience (NASDAQ:CERT)
Seeking Alpha· 2025-11-07 01:56
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Doximity outlines 13% full-year revenue growth target as AI suite accelerates client adoption (NYSE:DOCS)
Seeking Alpha· 2025-11-07 01:56
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
AEye outlines path to scale Apollo with $84M cash and 12 customer contracts while expanding manufacturing capacity (NASDAQ:LIDR)
Seeking Alpha· 2025-11-07 01:56
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Certara, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:CERT) 2025-11-06
Seeking Alpha· 2025-11-07 01:56
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Oil heads for second weekly loss as supply concerns weigh
Reuters· 2025-11-07 01:56
Oil edged up on Friday following three days of declines on worries about excess supply and slowing demand in the U.S., though prices appeared to be headed for a second week of losses. ...
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Molina Healthcare, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOH
Newsfile· 2025-11-07 01:51
Core Viewpoint - Rosen Law Firm is reminding investors who purchased Molina Healthcare, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Molina securities between February 5, 2025, and July 23, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by December 2, 2025 [3]. - Investors are encouraged to select qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Case Allegations - The lawsuit alleges that Molina's management failed to disclose several material adverse facts, including issues related to medical cost trend assumptions and the dislocation between premium rates and medical costs [5]. - It is claimed that Molina's near-term growth relied on a lack of utilization of various health services, which could lead to a significant cut in financial guidance for fiscal year 2025 [5]. - The lawsuit asserts that the positive statements made by Molina's management regarding the company's business and prospects were materially misleading [5].
INSP INVESTOR ALERT: Inspire Medical Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead the Inspire Medical Class Action Lawsuit – RGRD Law
Globenewswire· 2025-11-07 01:51
SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Inspire Medical Systems, Inc. (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”), have until January 5, 2026 to seek appointment as lead plaintiff of the Inspire Medical class action lawsuit. Captioned City of Pontiac Reestablished General Employees’ Retirement System v. Inspire Medical Systems, Inc., No. 25-cv-04247 (D. Minn.), the Inspire ...
Aura Minerals Announces Exercise of Warrants in Altamira Gold Corp.
Globenewswire· 2025-11-07 01:50
ROAD TOWN, British Virgin Islands, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (NASDAQ: AUGO) (B3: AURA33) (“Aura” or the “Company”) announces that it has exercised 24,000,000 common share purchase warrants (each, a “Warrant”) of Altamira Gold Corp. (the “Issuer” or “Altamira”) at an exercise price of CAD$0.20 per Warrant. Each Warrant was exercisable for one common share (each, a “Share”) of the Issuer. Immediately prior to the acquisition of the securities described in this press release, Aura ow ...
Peloton Promotes New Equipment Amid Recall of Old Bikes
PYMNTS.com· 2025-11-07 01:48
Core Insights - Peloton is facing a recall of certain Original Series Bike+ models due to reports of seat post breakage, affecting 833,000 bikes in the U.S. and 44,800 in Canada [2][3] - The recall is expected to cost the company approximately $16.5 million [4] Product Launch and Strategy - Peloton launched a new product lineup on October 1, which includes the Cross Training Series bike, treadmill, rowing machine, and an AI-assisted feature called Peloton IQ [5] - The new products are designed to help members achieve their wellness goals and include features like a swivel screen for easier exercise transitions and advanced computer vision for real-time suggestions [6] Market Response and Engagement - Since the launch of the new series, Peloton has observed a favorable shift towards premium products, particularly in treadmill and Plus line sales, attributed to excitement around advanced features [7] - Recent additions to Peloton's offerings include the Breathwrk app, micro-stores, a retail partnership with Johnson Fitness & Wellness, and a loyalty program called Club Peloton, which has engaged 500,000 members [8]
US to block Nvidia's sale of scaled-back AI chips to China, The Information says
Reuters· 2025-11-07 01:47
Core Insights - The White House has decided to prohibit Nvidia from selling its latest scaled-down AI chips to China, as reported by The Information, citing three sources familiar with the situation [1] Group 1 - The decision reflects ongoing tensions between the U.S. and China regarding technology and trade [1] - Nvidia's latest AI chips are considered critical for advancements in artificial intelligence, making this restriction significant for both companies and the industry [1] - The move may impact Nvidia's revenue and market strategy, particularly in the Chinese market, which is a key area for growth [1]